Prevention and control of influenza. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
These recommendations update for 1985-86 the information on the vaccine and antiviral agent available for control of influenza. Changes include addition of statements about the route of vaccine administration; the use of amantadine in medical personnel during influenza A outbreaks; the need to prepare contingency plans to expedite use of amantadine in aborting influenza A outbreaks among residents of institutions; and reduction in the dosage of amantadine for older patients or persons with seizure disorders.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000547:Amantadine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001428:Bacterial Vaccines / Q000008:administration & dosage; D002318:Cardiovascular Diseases; D002487:Centers for Disease Control and Prevention, U.S.; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D007251:Influenza, Human / Q000150:complications / Q000517:prevention & control*; D008875:Middle Aged; D022242:Pneumococcal Vaccines; D011247:Pregnancy; D012140:Respiratory Tract Diseases; D012306:Risk; D014481:United States; D014613:Vaccines, Attenuated
D001428:Bacterial Vaccines; D007252:Influenza Vaccines; D022242:Pneumococcal Vaccines; D014613:Vaccines, Attenuated; D000547:Amantadine